The use of extracorporeal membrane oxygenation in human immunodeficiency virus-positive patients: a review of a multicenter database.
Thomas V BroganRavi R ThiagarajanRoberto LorussoD Michael McMullanMatteo Di NardoMark T OginoHeidi J DaltonChristopher R BurkeGerry CapatosPublished in: Perfusion (2020)
Survival among patients with human immunodeficiency virus infection who receive extracorporeal membrane oxygenation was less than 40%. Infections before extracorporeal membrane oxygenation cannulation occurred more often in non-survivors. The receipt of renal replacement therapy, inotropic infusions, or cardiopulmonary resuscitation during extracorporeal membrane oxygenation was associated with worse outcome.
Keyphrases
- extracorporeal membrane oxygenation
- human immunodeficiency virus
- acute respiratory distress syndrome
- hepatitis c virus
- cardiopulmonary resuscitation
- antiretroviral therapy
- cardiac arrest
- respiratory failure
- hiv infected
- end stage renal disease
- ejection fraction
- hiv aids
- newly diagnosed
- chronic kidney disease
- hiv positive
- acute kidney injury
- peritoneal dialysis
- mechanical ventilation
- clinical trial
- emergency department
- hiv testing
- free survival